Patent · US Active

Oncogenic ras-specific cytotoxic compound and methods of use thereof

US8883841B2 · kind B2 · utility

2Cited by
3References
52Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 22, 2006
Grant dateNov 11, 2014
Priority date—
Expiry dateNov 30, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Embodiments of the present invention provide for methods and compositions comprising an Oncorasin, such as 1-[(4-chlorophenyl)methyl]-1H-Indole-3-carboxaldehyde (oncrasin-1) and/or its analogs or derivatives.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.